Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
---|
01/03/1997 | WO1997000063A2 Urocortin peptides |
01/03/1997 | WO1996037621A3 Multimeric proteins |
01/03/1997 | CA2245835A1 Novel high affinity human antibodies to tumor antigens |
01/03/1997 | CA2224697A1 Rotavirus enterotoxin nsp4 and methods of using same |
01/03/1997 | CA2224646A1 Chimeric leptin fused to immunoglobulin domain and use |
01/03/1997 | CA2224625A1 P-selectin ligands and related molecules and methods |
01/03/1997 | CA2224560A1 Anti-metastatic and anti-angiogenic pharmaceutical compositions |
01/03/1997 | CA2223792A1 Urocortin peptides |
01/02/1997 | EP0751147A1 Toxoplasma gondii antigen, its production and use |
01/02/1997 | EP0750666A1 HUMAN trk RECEPTORS AND NEUROTROPHIC FACTOR INHIBITORS |
01/02/1997 | EP0750637A1 Dna encoding cai resistance proteins and uses thereof |
01/02/1997 | EP0750628A1 Fibroblast growth factor-10 |
01/02/1997 | EP0750626A1 Corpuscles of stannius protein, stanniocalcin |
01/02/1997 | EP0750514A1 Immunotherapeutic method of treating cancerous diseases by administration of gamma globulins |
01/02/1997 | EP0750512A1 A medical use of matrix metalloproteinase inhibitors for inhibiting tissue contraction |
01/02/1997 | EP0750510A1 Skin treatment composition |
01/02/1997 | EP0750509A1 Use of il-12 and il-12 antagonists in the treatment of autoimmune diseases |
01/02/1997 | EP0750508A1 RETROPEPTIDES, ANTIBODIES THERETO, AND USES THEREOF FOR VACCINATION AND $i(IN VITRO) DIAGNOSIS |
01/02/1997 | EP0654082A4 CLONING AND EXPRESSION OF A HUMAN -g(a)(1,3)FUCOSYLTRANSFERASE, FUCT-VI. |
01/02/1997 | EP0538341B1 Ehv-4 glycoprotein vaccine |
01/01/1997 | CN1139115A Anti-aV-integrin monoclonal antibody |
12/31/1996 | US5589579 Gene sequence and probe for a marker of non-small cell lung carinoma |
12/31/1996 | US5589575 Purification of hapten-carrier generated antibodies |
12/31/1996 | US5589573 Amino acid sequences of anti-idiotypic antibodies against anti-cancer human monoclonal antibody, and DNA base sequences encoding those sequences |
12/31/1996 | US5589570 Integrin alpha subunit cytoplasmic domain polypeptides and methods |
12/31/1996 | US5589459 Synthetic peptides for detoxification of bacterial endotoxins and for the prevention and treatment of septic shock |
12/31/1996 | US5589456 Dna and expression vectors |
12/31/1996 | US5589380 Isolated DNA molecule encoding SHET1 of Shigella flexneri 2a and mutant Shigella flexneri 2a |
12/31/1996 | US5589375 Dephosphorylation |
12/31/1996 | US5589359 Chimeric proteins |
12/31/1996 | US5589358 Ileal bile acid transporter compositions and methods |
12/31/1996 | US5589345 Leukemia cells |
12/31/1996 | US5589343 Antibodies which bind to molecules containing at least one peptide sequence carrying one or several epitopes characteristic of a liver stage antigen produced by P. falciparum in hepatocytes |
12/31/1996 | US5589174 Anti-human influenza virus antibody |
12/31/1996 | CA2180280A1 Adenyl-cyclase-hemolysin (ac-hly)-protecting epitopes; use thereof for the treatment or the prevention of infections by bordetella |
12/31/1996 | CA2019745C Preparation for treating and preventing thromboses and thromboembolic complications, use of such a preparation and a method of producing the same |
12/27/1996 | WO1996042016A1 Use of a phycobiliprotein-binding peptide complex as a fluorescent tracer |
12/27/1996 | WO1996041887A1 Dnase-active protein |
12/27/1996 | WO1996041880A1 Adherence gene from helicobacter pylori and polypeptide coded thereby |
12/27/1996 | WO1996041878A1 Nucleic acid molecule and its uses in determining pathogenicity of staphylococcus |
12/27/1996 | WO1996041877A2 Malarial pre-erythrocytic stage polypeptide molecules |
12/27/1996 | WO1996041875A1 p-53 BINDING PROTEIN CALLED Mdmx AND ENCODING SEQUENCES FOR SAID PROTEIN |
12/27/1996 | WO1996041624A1 TNF-α CONVERTING ENZYME |
12/27/1996 | WO1996041620A1 Fgfr3 as a marker for mesenchymal skeletal progenitor cells |
12/27/1996 | WO1996041608A2 Pyrularia thionin containing immunotoxins and immunotoxin-like conjugates |
12/27/1996 | WO1996041606A2 Improved pharmaceutical compositions for gene therapy |
12/27/1996 | WO1996041523A1 Fgf9 as a specific ligand for fgfr3 |
12/27/1996 | WO1996035784A3 Chromatin-regulator genes |
12/27/1996 | WO1996031607A3 Use of an 'immunodeficiency-virus suppressing lymphokine (isl)' to inhibit the replication of viruses, in particular of retroviruses |
12/27/1996 | EP0750037A2 TNF-convertase and method measuring inhibition of TNF convertase |
12/27/1996 | EP0749981A1 Monoclonal antibody |
12/27/1996 | EP0749496A1 Human dna mismatch repair proteins |
12/27/1996 | EP0749494A1 Compositions for the inhibition of tnf formation and uses thereof |
12/27/1996 | EP0749488A1 Anti-il-8 monoclonal antibodies for treatment of inflammatory disorders |
12/27/1996 | EP0749487A1 Cell surface protein and effector cell bonding reagent |
12/27/1996 | EP0749482A1 Recombinant humanized anti-lewis y antibodies |
12/27/1996 | EP0749481A1 Humanized monoclonal antibodies against human interleukin-4 |
12/27/1996 | EP0749480A1 Novel forms of t cells costimulatory molecules and uses therefor |
12/27/1996 | EP0749445A1 Antibodies which bind the g-csf receptor extracellular domain and methods of treatment |
12/27/1996 | EP0749443A1 Fk-506 cytosolic binding protein |
12/27/1996 | EP0749439A1 Nucleotide or nucleoside photoaffinity compound modified antibodies, methods for their manufacture and use thereof |
12/27/1996 | EP0749325A1 Bispecific molecules having clinical utilities |
12/27/1996 | EP0749323A1 Methods for modulating t cell unresponsiveness |
12/27/1996 | EP0749322A1 VACUOLATING TOXIN-DEFICIENT $i(H. PYLORI) AND RELATED METHODS |
12/27/1996 | EP0749320A1 Fibrin-specific antibody for use as an antithrombotic agent |
12/27/1996 | EP0749319A1 Immortalized cells and uses therefor |
12/27/1996 | EP0749312A1 $i(DIROFILARIA IMMITIS) Gp29 PROTEINS, NUCLEIC ACID MOLECULES AND USES THEREOF |
12/27/1996 | EP0332651B2 Method of isolating ca 125 antigen |
12/27/1996 | CA2253496A1 Adherence gene from helicobacter pylori and polypeptide coded thereby |
12/27/1996 | CA2224229A1 Fgfr3 as a marker for mesenchymal skeletal progenitor cells |
12/27/1996 | CA2222208A1 P-53 binding protein called mdmx and encoding sequences for said protein |
12/27/1996 | CA2221029A1 Malarial pre-erythrocytic stage polypeptide molecules |
12/25/1996 | CN1138865A Peptides and methods against psoriasis |
12/25/1996 | CN1138863A Chimeric proteins which block complement activation |
12/24/1996 | US5587459 Linked to a ligand targeting a cell surface receptor; for treating cancers and autoimmune diseases |
12/24/1996 | US5587458 Anti-erbB-2 antibodies, combinations thereof, and therapeutic and diagnostic uses thereof |
12/24/1996 | US5587455 Hybrid protein comprising virus binding region from cd4 cellular receptor sequence linked to protein toxin sequence containing region essential for cell toxicity |
12/24/1996 | US5587306 Dna sequences |
12/24/1996 | US5587302 T cell growth factor |
12/24/1996 | US5587287 Thermostable polymerase specific antibody-containing DNA amplification composition and kit |
12/24/1996 | US5587166 Killed whole cells of pasteurella hemolytica grown under iron-restriction conditions in vitro, adjuvant |
12/24/1996 | US5587162 Administering to mammal a cytotoxin |
12/24/1996 | CA1338807C Plasmid vector with pectate lyase signal sequence |
12/19/1996 | WO1996041291A1 A method and apparatus for predicting the presence of congenital and acquired imbalances and therapeutic conditions |
12/19/1996 | WO1996041190A1 Monospecific antibodies and methods using them |
12/19/1996 | WO1996041183A1 Differential assay for ulcerative colitis, primary sclerosing cholangitis and type 1 autoimmune hepatitis |
12/19/1996 | WO1996041175A1 Electrochemiluminescent enzyme immunoassay |
12/19/1996 | WO1996041170A1 Monospecific antibodies against a subunit of fibrinogen |
12/19/1996 | WO1996041168A1 Monospecific antibodies and methods using them |
12/19/1996 | WO1996041167A1 Relaxin diagnostic assays and kits, and methods and uses thereof |
12/19/1996 | WO1996041020A1 Fluorescence resonance energy transfer screening assay for the identification of hiv-1 envelope glycoprotein-medicated cell |
12/19/1996 | WO1996040986A1 Calibrator for use in a soluble fibrin assay |
12/19/1996 | WO1996040960A1 A method for promoting enzyme diversity |
12/19/1996 | WO1996040942A1 Humanized antibodies to e-selectin |
12/19/1996 | WO1996040941A1 Chimeric antibodies for delivery of antigens to selected cells of the immune system |
12/19/1996 | WO1996040940A2 A human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases |
12/19/1996 | WO1996040932A1 Vaccine for porcine reproductive and respiratory syndrome virus |
12/19/1996 | WO1996040931A1 Neutralizing conformational epitopes of chicken anemia virus |
12/19/1996 | WO1996040928A1 Streptococcal heat shock proteins members of the hsp70 family |
12/19/1996 | WO1996040927A1 Isospora suis vaccine |